Unleash the potential of liquid biopsy with Caris Assure, an innovative multi-cancer assay that provides deep molecular insights from a simple blood sample. Explore how this powerful liquid biopsy assay can revolutionize patient care. Start ordering: https://lnkd.in/gZm92Zdg #molecularprofiling #precisionmedicine #liquidprofiling
Caris Life Sciences
Biotechnology Research
Irving, Texas 55,359 followers
Fulfilling the promise of precision medicine through quality and innovation.
About us
Caris Life Sciences® (Caris) is the leading next-generation TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition. Through comprehensive molecular profiling (Whole Exome and Whole Transcriptome Sequencing) and the application of advanced artificial intelligence (AI) and machine learning algorithms, Caris has created the large-scale, clinico-genomic database and computing capability needed to analyze and unravel the molecular complexity of disease. This convergence of sequencing power, big data and AI technologies provides an unmatched platform to deliver the next-generation of precision medicine tools for early detection, diagnosis, monitoring, therapy selection and drug development. Headquartered in Irving, Texas, Caris has offices in Phoenix, New York, Tokyo, Japan and Basel, Switzerland. Caris or its distributor partners provide services in the U.S., Europe, Asia and other international markets.
- Website
-
https://www.carislifesciences.com
External link for Caris Life Sciences
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Irving, Texas
- Type
- Privately Held
- Founded
- 1996
- Specialties
- Biotechnology, Molecular Profiling, Genomics, Personalized Medicine, Diagnostics, Theranostics, Panomics, Precision Medicine, and Comprehensive Genomic Profiling
Locations
-
Primary
750 W John Carpenter Fwy
Irving, Texas 75039, US
-
4610 S 44th Pl
Phoenix, Arizona 85040, US
-
St. Jakobsstrasse
199, 4052 Basel, CH
Employees at Caris Life Sciences
Updates
-
Caris Life Sciences is committed to bringing awareness to sarcoma cancers. During Sarcoma Awareness Month, we are focused on educating individuals about the importance of molecular profiling in changing the course of treatment. Learn more about how Caris testing can make a difference: https://ow.ly/4jYE50StOrx #SarcomaAwarenessMonth
-
Following a great ASCO 2024, we spotlight Dr. George Sledge, Jr., former President of ASCO and current Caris Chief Medical Officer. In this feature, he shares his conference insights, his journey as an oncologist and how his passion for precision medicine led him to Caris. Learn More: https://lnkd.in/gGrtUEEB
-
-
Caris expands its extensive network of leading cancer institutions committed to improving patient outcomes through innovations in precision medicine by welcoming Mass General Cancer Center. “We are thrilled to welcome Mass General Cancer Center, one of the world’s most respected centers, to the Caris Precision Oncology Alliance,” said George Sledge, Jr., MD, EVP and Chief Medical Officer of Caris. “We’re eager to work with their researchers and investigators on our shared mission of improving outcomes of all patients affected by cancer through precision oncology research.” Learn more: https://lnkd.in/ggni-zgg
-
-
June is Men's Health Month, and at Caris Life Sciences, we're committed to helping men receive personalized cancer care. Discover how molecular profiling can be beneficial: https://lnkd.in/gZ_sUcny #MensHealthMonth
-
-
Caris Life Sciences reposted this
Join us today at the 2024 AACI CRI meeting for a special session from 4:00 - 4:30 pm at the Pollack Room in the Loews Hotel. This joint session, hosted by Caris Life Sciences, Thomas Jefferson University, and CancerLinQ, a ConcertAI initiative, will delve into the "Real World Application of Precision Medicine Technology to Accelerate Clinical Trials." Hope to see you there! #AACICRI #PrecisionMedicine #ClinicalTrials #HealthcareInnovation
-
-
Caris Life Sciences reposted this
We are thrilled to announce that Juniper Biologics has acquired the distribution rights for Caris Life Sciences' tumor molecular profiling services across the Middle East and Africa. This empowers oncologists to recommend highly personalized treatments tailored specifically to a patient's cancer, enhancing and expanding their care options. By leveraging this targeted approach, we aim to improve the quality of life for patients, especially those with rare or aggressive cancers. Read the news here: https://lnkd.in/gkRkqYXx #juniperbiologics #acquisition #healthcare #cancercare #oncology
-
-
June is National Cancer Survivor Month, and we are honoring the incredible strength and resilience of cancer patients, caregivers and families. Join us in celebrating these brave individuals and learn how we can continue to support those with cancer. Learn more: https://lnkd.in/gttPBvN3 #NationalCancerSurvivorMonth
-
Unleash the power of liquid biopsy with Caris Assure. This groundbreaking multi-cancer assay offers deep molecular insights from a simple blood sample. Discover how this powerful liquid biopsy assay can transform patient care. Learn more: https://ow.ly/Vxvn50QSvoc
Less Invasive, More Intelligent Than Ever
-
That’s a wrap for ASCO 2024! We want to express our sincere gratitude to the numerous visitors who graced the Caris Life Sciences booth with their presence. It was a pleasure engaging with each of you to explore avenues for advancing precision medicine. Caris remains steadfast in its dedication to improving as many lives as possible. Discover more about our mission: https://lnkd.in/gX69hvc5 #ASCO24 #precisionmedicine